Texas Instruments' Q1 beat and full-year guidance set up a second-half revenue trajectory that pushes run-rate EPS above $9—a normalization path the market started pricing April 30.
Texas Instruments' Q1 beat and full-year guidance set up a second-half revenue trajectory that pushes run-rate EPS above $9—a normalization path the market started pricing April 30.
Marijuana entrepreneurs are usually so busy with their dreams and goals, not to mention the day-to-day details of nurturing a startup to full maturity,...